The SLC45A2 gene albinism oculocutaneous type 4 genetic test is a specialized diagnostic procedure designed to identify mutations in the SLC45A2 gene, which are responsible for causing oculocutaneous albinism type 4 (OCA4). OCA4 is a form of albinism characterized by reduced pigmentation in the hair, skin, and eyes, and can also lead to vision problems. This condition is inherited in an autosomal recessive pattern, meaning that two copies of the mutated gene, one from each parent, are necessary for an individual to be affected.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The procedure involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab to detect the presence of mutations in the SLC45A2 gene. This test is crucial for the accurate diagnosis of OCA4, enabling affected individuals and their families to receive proper genetic counseling and to understand the implications of the condition.
The cost of the SLC45A2 gene albinism oculocutaneous type 4 genetic test at DNA Labs UAE is 4400 AED. This cost reflects the comprehensive nature of the test, from sample collection to detailed genetic analysis and reporting. For families and individuals seeking clarity on OCA4 status, this test provides essential genetic insights that can guide medical and personal decision-making.
The C10ORF11 gene plays a critical role in the development of oculocutaneous albinism type 5 (OCA5), a rare genetic condition characterized by reduced pigmentation in the hair, skin, and eyes, and often accompanied by vision problems. OCA5 is a result of mutations in the C10ORF11 gene, which is involved in the biological pathways that produce melanin, the pigment responsible for color in these tissues.
DNA Labs UAE offers a specialized genetic test designed to identify mutations in the C10ORF11 gene, providing a definitive diagnosis for individuals suspected of having oculocutaneous albinism type 5. This test is crucial for early detection and management of the condition, which can help in addressing the vision problems and skin sensitivity to sunlight associated with OCA5.
The cost of the C10ORF11 gene albinism oculocutaneous type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations within the C10ORF11 gene that lead to the development of OCA5. By confirming the diagnosis, affected individuals and their families can gain a better understanding of the condition, leading to informed decisions about care and management.
The PAX6 Gene Aniridia Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PAX6 gene, which are strongly associated with aniridia. Aniridia is a rare genetic disorder characterized by the partial or complete absence of the iris in the eye, leading to various visual impairments and potentially other ocular complications. The PAX6 gene plays a crucial role in eye development, and mutations in this gene can disrupt this process, resulting in aniridia or related eye conditions.
This test is particularly valuable for individuals who have a family history of aniridia or exhibit symptoms related to the condition, as it can provide definitive genetic evidence of the PAX6 mutation. Early identification of the mutation can aid in managing the disorder, guiding treatment options, and offering genetic counseling for affected families.
The cost of the PAX6 Gene Aniridia Genetic Test at DNA Labs UAE is set at 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and subsequent detailed analysis in the laboratory. The test results can offer crucial insights into the genetic underpinnings of aniridia, enabling healthcare providers to tailor their approach to the specific needs of the patient and their family.
The "PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the PITX3 gene, which are associated with anterior segment mesenchymal dysgenesis (ASMD). ASMD is a rare genetic disorder affecting the eyes, leading to various abnormalities in structures like the cornea, iris, and lens, which can result in visual impairment or blindness. This test is particularly valuable for families with a history of ASMD, enabling early diagnosis and intervention to manage the condition more effectively. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the PITX3 gene. Through this test, individuals and families can gain essential insights into their genetic makeup, facilitating informed decisions regarding healthcare and management of the disorder.
The CEP290 Gene Bardet-Biedl Syndrome Type 14 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CEP290 gene, which are associated with Bardet-Biedl Syndrome Type 14 (BBS14). This syndrome is a complex genetic disorder that affects multiple body systems, leading to symptoms such as vision loss, kidney dysfunction, obesity, learning disabilities, and polydactyly (extra fingers or toes). The test is crucial for early diagnosis, enabling timely intervention and management of the condition.
At DNA Labs UAE, the test is conducted with precision and care, utilizing advanced genetic sequencing techniques to accurately detect the presence of mutations in the CEP290 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to carry out the analysis. Early detection through this genetic test can significantly impact the quality of life for individuals with Bardet-Biedl Syndrome Type 14, offering insights into potential treatments and preventive measures for associated complications.
The BEST1 gene bestrophinopathy genetic test is a specialized diagnostic tool used to detect mutations in the BEST1 gene, which are associated with a group of eye disorders known as bestrophinopathies. These disorders can lead to a range of visual impairments, including reduced vision, distorted vision, and in some cases, progressive loss of vision. The conditions linked to mutations in the BEST1 gene include Best vitelliform macular dystrophy, adult-onset vitelliform macular dystrophy, autosomal dominant vitreoretinochoroidopathy, and autosomal recessive bestrophinopathy.
This genetic test is performed to confirm a diagnosis, guide treatment plans, and provide information for family planning. It involves analyzing the patient's DNA to identify any mutations in the BEST1 gene that may be responsible for the development of bestrophinopathies.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the BEST1 gene bestrophinopathy genetic test is 4400 AED. This price may cover the collection of the sample, usually through a blood draw or cheek swab, the genetic analysis, and a detailed report explaining the results. It is advisable for patients to consult with a healthcare provider or a genetic counselor before and after undergoing genetic testing to understand the implications of the test results fully.
The CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CYP4V2 gene, which are linked to Bietti Crystalline Corneoretinal Dystrophy (BCD). BCD is a rare genetic eye disorder characterized by the progressive loss of vision, the presence of crystal-like deposits in the retina, and the degeneration of the retina and choroid. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the CYP4V2 gene, helping in the diagnosis and management of the condition. By identifying the genetic basis of BCD, this test plays a crucial role in understanding the risk of disease progression, potential treatment approaches, and the likelihood of passing the condition to future generations.
The FOXL2 gene test is a specialized genetic analysis designed to diagnose conditions associated with mutations in the FOXL2 gene, notably Blepharophimosis, Epicanthus Inversus, and Ptosis (BPES). BPES is a rare genetic disorder that affects the development of the eyes and eyelids, leading to distinctive facial features. The condition is characterized by a narrowing of the eye opening (blepharophimosis), an inward folding of the skin of the upper eyelid (epicanthus inversus), and drooping of the upper eyelids (ptosis). In some cases, BPES can also impact ovarian function, leading to premature ovarian failure in women.
The FOXL2 gene test involves analyzing the patient's DNA to identify mutations in the FOXL2 gene, which plays a crucial role in eyelid and ovarian development. Identifying mutations in this gene can confirm a diagnosis of BPES, assist in understanding the risk of passing the condition to offspring, and guide management and treatment decisions.
In the United Arab Emirates, DNA Labs UAE offers this genetic test at a cost of 4400 AED. DNA Labs UAE is known for its advanced genetic testing services, providing accurate and reliable results. The test is conducted in a state-of-the-art laboratory by a team of specialized geneticists and healthcare professionals, ensuring high-quality standards and confidentiality of patient information.
The UBE3B Gene Blepharophimosis-Ptosis-Intellectual Disability Syndrome Genetic Test is a specialized diagnostic tool used to identify mutations in the UBE3B gene, which are linked to a rare genetic disorder. This condition is characterized by a combination of facial anomalies including blepharophimosis (a condition where the eyelids are horizontally shortened), ptosis (drooping of the upper eyelid), and intellectual disability among other possible features.
DNA Labs UAE offers this comprehensive genetic test to help in the diagnosis and management of individuals suspected of having this syndrome. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the UBE3B gene that are known to cause the disorder.
The cost of the UBE3B Gene Blepharophimosis-Ptosis-Intellectual Disability Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment can be crucial for affected families, providing them with a definitive diagnosis and enabling healthcare providers to tailor management and support strategies to the individual's needs, potentially improving quality of life and outcomes.
The RLBP1 Gene Bothnia Retinal Dystrophy Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RLBP1 gene, which are associated with Bothnia Retinal Dystrophy. This genetic condition is a form of retinal dystrophy that predominantly affects vision, leading to symptoms such as night blindness and progressive loss of visual fields. Early and accurate diagnosis through genetic testing is crucial for the management and understanding of the condition, allowing affected individuals and their families to make informed decisions regarding treatment and lifestyle adjustments.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the RLBP1 gene. DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results.
